238 related articles for article (PubMed ID: 33974984)
1. Risk Factors for High-Grade Meningioma in Brain and Spine: Systematic Review and Meta-analysis.
Shin HK; Park JH; Cho YH; Kim YH; Hong SH; Kim JH; Roh SW; Jeon SR
World Neurosurg; 2021 Jul; 151():e718-e730. PubMed ID: 33974984
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and individual participant data meta-analysis of gonadal steroid hormone receptors in meningioma.
Miyagishima DF; Sundaresan V; Gutierrez AG; Barak T; Yeung J; Moliterno J; McGuone D; Claus EB; Günel M
J Neurosurg; 2023 Dec; 139(6):1638-1647. PubMed ID: 37243565
[TBL] [Abstract][Full Text] [Related]
3. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
[TBL] [Abstract][Full Text] [Related]
4. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
5. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
Ressel A; Fichte S; Brodhun M; Rosahl SK; Gerlach R
J Neurooncol; 2019 Nov; 145(2):277-286. PubMed ID: 31578671
[TBL] [Abstract][Full Text] [Related]
6. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
7. Anatomic location is a risk factor for atypical and malignant meningiomas.
Kane AJ; Sughrue ME; Rutkowski MJ; Shangari G; Fang S; McDermott MW; Berger MS; Parsa AT
Cancer; 2011 Mar; 117(6):1272-8. PubMed ID: 21381014
[TBL] [Abstract][Full Text] [Related]
8. Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.
Cornelius JF; Slotty PJ; Steiger HJ; Hänggi D; Polivka M; George B
Acta Neurochir (Wien); 2013 Mar; 155(3):407-13. PubMed ID: 23318687
[TBL] [Abstract][Full Text] [Related]
9. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
Gousias K; Schramm J; Simon M
J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
[TBL] [Abstract][Full Text] [Related]
10. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
McGovern SL; Aldape KD; Munsell MF; Mahajan A; DeMonte F; Woo SY
J Neurosurg; 2010 May; 112(5):925-33. PubMed ID: 19799498
[TBL] [Abstract][Full Text] [Related]
11. Effect of dural detachment on long-term tumor control for meningiomas treated using Simpson grade IV resection.
Fukushima Y; Oya S; Nakatomi H; Shibahara J; Hanakita S; Tanaka S; Shin M; Kawai K; Fukayama M; Saito N
J Neurosurg; 2013 Dec; 119(6):1373-9. PubMed ID: 24053497
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing grade I meningioma from higher grade meningiomas without biopsy.
Varlotto J; Flickinger J; Pavelic MT; Specht CS; Sheehan JM; Timek DT; Glantz MJ; Sogge S; Dimaio C; Moser R; Yunus S; Fitzgerald TJ; Upadhyay U; Rava P; Tangel M; Yao A; Kanekar S
Oncotarget; 2015 Nov; 6(35):38421-8. PubMed ID: 26472106
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.
Nakasu S; Nakasu Y
Brain Tumor Pathol; 2021 Apr; 38(2):81-95. PubMed ID: 33403457
[TBL] [Abstract][Full Text] [Related]
14. [Relevance of Simpson's grading system for resections in WHO grade I meningiomas].
Otero A; Tabernero MD; Muñoz MC; Sousa P; Miranda D; Pascual D; Gonçalves JM; Ruiz L
Neurocirugia (Astur); 2017; 28(4):176-182. PubMed ID: 28242156
[TBL] [Abstract][Full Text] [Related]
15. Meningothelioma as the predominant histological subtype of midline skull base and spinal meningioma.
Lee JH; Sade B; Choi E; Golubic M; Prayson R
J Neurosurg; 2006 Jul; 105(1):60-4. PubMed ID: 16871881
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for high-grade transformation in benign meningiomas.
Kwon SM; Kim JH; Yoo HJ; Kim YH; Hong SH; Cho YH; Kim CJ; Nam SJ
Clin Neurol Neurosurg; 2020 Aug; 195():105897. PubMed ID: 32505062
[TBL] [Abstract][Full Text] [Related]
17. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
[TBL] [Abstract][Full Text] [Related]
18. Intracranial Meningioma in Patients Age <35 Years: Evolution of the Disease in the Era of Human Immunodeficiency Virus Infection.
Motebejane MS; Kaminsky I; Choi IS
World Neurosurg; 2018 Jan; 109():e292-e297. PubMed ID: 28987830
[TBL] [Abstract][Full Text] [Related]
19. Meningioma grading: an analysis of histologic parameters.
Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
Am J Surg Pathol; 1997 Dec; 21(12):1455-65. PubMed ID: 9414189
[TBL] [Abstract][Full Text] [Related]
20. Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence.
Zhang H; Ma L; Wang YB; Shu C; Kuang W; Huang YA; Dong LQ; Cheng GG
World Neurosurg; 2017 Jan; 97():693-700.e11. PubMed ID: 27744084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
